This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03955/identifier/pdb/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03955/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03955/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03955/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03955
rdf:type
n3:Drug
n3:description
An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity. [PubChem]
n3:group
experimental
owl:sameAs
n6:DB03955 n13:DB03955
dcterms:title
1,5-Dideoxy-1,5-Imino-D-Mannitol
adms:identifier
n8:44387838 n10:46509136 n11:DB03955 n12:DDM
n3:IUPAC-Name
n4:271B5335-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B533B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B533A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5337-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5338-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5339-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5333-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5331-363D-11E5-9242-09173F13E4C5 n4:271B5334-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5332-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5341-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5342-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B533C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B533D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B533F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B533E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5340-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5347-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5349-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B534A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5346-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5345-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5348-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5336-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5343-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5344-363D-11E5-9242-09173F13E4C5